113
Views
15
CrossRef citations to date
0
Altmetric
Original

Gene expression profiles reveal homeostatic dynamics during interferon-β therapy in multiple sclerosis

, , , , , , , , , , & show all
Pages 16-22 | Received 20 Sep 2006, Accepted 22 Nov 2006, Published online: 07 Jul 2009
 

Abstract

Understanding the mechanisms that sustain the effects of disease modifying drugs in multiple sclerosis (MS) may help refine current therapies and improve our knowledge of disease pathogenesis.

By using cDNA microarrays, we investigated gene expression in the peripheral blood mononuclear cells (PBMC) of 7 MS patients, at baseline (T0) as well as after 1 (T1) and 3 months (T3) of interferon beta-1a (IFN-β-1a; Rebif™ 44 μg) therapy.

Gene expression changes involved genes of both immunological and non-immunological significance. We validated IL-10 up-regulation, which is in accordance with previous reports, and other novel changes that underscore the capacity of IFN-β to impair antigen presentation and migration of inflammatory elements into the central nervous system (up-regulation of filamin B and down-regulation of IL-16 and rab7).

Overall, gene expression changes became less pronounced after 3 months of therapy, suggesting a homeostatic response to IFN-β. This may be of use for the design of new treatment schedules.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.